PHAT
Phathom Pharmaceuticals Inc
7.10$
+4.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +180.4% | +283.1% | +123.3% | +81.4% | -3.9% | +38.5% | +25.3% | +16.3% | +1.2% | +27.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +4.8% | -0.8% | +3.8% | -5.2% | +16.4% | +17.4% | -4.0% | -13.1% | -15.8% | -1.6% | +190.9% | +21.0% | +223.0% | +71.2% | +61.9% | -2.4% | +35.3% | +22.9% | +23.6% | +56.9% | +25.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +350.3% | +300.3% | +135.3% | +84.7% | -4.1% | +39.0% | +25.7% | +15.3% | -7.3% | +27.8% | – | |
| – | – | – | +133.3% | +2,964.3% | +18,937.1% | -94.5% | +184.3% | +24.9% | -6.3% | +73.4% | +61.6% | -50.6% | +4.9% | -23.1% | -18.4% | +30.3% | +6.5% | +1.1% | -16.2% | -28.0% | +11.2% | -3.9% | +9.2% | -29.6% | -21.8% | +17.9% | -1.3% | +7.0% | -1.2% | -22.6% | +6.6% | +3.7% | +0.5% | – | |
| – | +0.0% | +3.6% | +66.8% | +82.4% | +68.8% | +34.8% | +64.9% | +50.9% | +14.5% | +36.8% | +52.8% | +20.6% | +5.5% | +20.5% | +17.9% | +3.9% | +31.1% | -11.4% | +30.6% | -39.4% | +1.8% | +23.5% | +160.4% | +0.0% | +24.5% | +0.3% | -0.3% | +24.5% | -9.7% | -39.6% | -6.2% | +11.7% | +2.4% | – | |
| – | +0.0% | +5.9% | +68.3% | +171.8% | +6,671.1% | -92.4% | +149.8% | +29.8% | -1.7% | +64.0% | +59.7% | -36.0% | +5.2% | -6.2% | -0.3% | +14.3% | +20.1% | -6.6% | +9.7% | -35.3% | +5.4% | +12.1% | +97.5% | +1.8% | +16.5% | +1.9% | +0.6% | +21.6% | -8.9% | -37.9% | -4.6% | +10.6% | +2.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +25.0% | +120.0% | +10,236.4% | +75.0% | -47.8% | -29.0% | +71.0% | +1.9% | +0.8% | -1.9% | -1.3% | +18.2% | +86.9% | -0.6% | +105.4% | +63.7% | +3.5% | -4.0% | +4.3% | +5.1% | +28.9% | +31.8% | +3.5% | +4.1% | +0.6% | -2.8% | -3.1% | -8.0% | +1.9% | -3.8% | -4.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +25.0% | +120.0% | +9,318.2% | +50.7% | -2,891.9% | – | -75.3% | +604.4% | -7.3% | +7.0% | -0.4% | -144.5% | – | – | +105.3% | +51.1% | -1.8% | -101.7% | – | -24.5% | -330.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.